Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.12), $0.13 worse than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.